Latest Mesenchymal stem cell Stories
Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection (TESI) with autologous mesenchymal stem cells and bone marrow mononuclear cells in patients with ischemic cardiomyopathy.
Learn How Stem Cell Therapy May Be Used in Various Chronic, Degenerative Conditions at a Series of Free Public Seminars Hosted By the Miami Stem Cell Treatment Center Miami,
Chicago Stem Cell Treatment Center, a research affiliate of Cell Surgical Network (CSN) provide stem cell therapy for a variety of degenerative conditions by deploying non-embryonic adult mesenchymal
Researchers at the University of Illinois at Chicago have identified a protein expressed by human bone marrow stem cells that guides and stimulates the formation of blood vessels.
A group of Brigham and Women’s Hospital, and Harvard Stem Cell Institute researchers, and collaborators at MIT and Massachusetts General Hospital have found a way to use stem cells as drug delivery vehicles.
GeneCell International, the only cord blood laboratory in South Florida, a cutting-edge facility, specialized in the processing and cryogenic preservation of umbilical cord blood, cord tissue
Scientists know that physical and biochemical signals can guide cells to make, for example, muscle, blood vessels or bone.
As stem cell clinical trials for multiple sclerosis (MS) patients become more common, it is crucial for researchers to understand the biologic changes and therapeutic effects of older donor stem